KRW 7620.0
(-0.78%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 475.42 Billion KRW | 70.84% |
2022 | 278.29 Billion KRW | -20.58% |
2021 | 350.39 Billion KRW | -0.93% |
2020 | 353.7 Billion KRW | 690.92% |
2019 | 44.72 Billion KRW | 30.71% |
2018 | 34.21 Billion KRW | 0.53% |
2017 | 34.03 Billion KRW | -21.66% |
2016 | 43.44 Billion KRW | -28.02% |
2015 | 60.35 Billion KRW | -11.62% |
2014 | 68.28 Billion KRW | 218.43% |
2013 | 21.44 Billion KRW | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1303.62 Billion KRW | 173.48% |
2024 Q1 | 476.67 Billion KRW | 0.26% |
2023 Q2 | 477.25 Billion KRW | 68.76% |
2023 Q4 | 475.42 Billion KRW | -2.54% |
2023 Q1 | 282.8 Billion KRW | 1.62% |
2023 FY | 475.42 Billion KRW | 70.84% |
2023 Q3 | 487.8 Billion KRW | 2.21% |
2022 Q4 | 278.29 Billion KRW | 2.01% |
2022 Q2 | 359.86 Billion KRW | 10.66% |
2022 Q1 | 325.21 Billion KRW | -7.19% |
2022 FY | 278.29 Billion KRW | -20.58% |
2022 Q3 | 272.81 Billion KRW | -24.19% |
2021 Q4 | 350.39 Billion KRW | -5.07% |
2021 Q2 | 370.78 Billion KRW | 15.3% |
2021 Q1 | 321.59 Billion KRW | -9.08% |
2021 Q3 | 369.11 Billion KRW | -0.45% |
2021 FY | 350.39 Billion KRW | -0.93% |
2020 Q4 | 353.7 Billion KRW | 5.93% |
2020 Q2 | 92.92 Billion KRW | 88.25% |
2020 FY | 353.7 Billion KRW | 690.92% |
2020 Q1 | 49.36 Billion KRW | 10.38% |
2020 Q3 | 333.88 Billion KRW | 259.31% |
2019 Q1 | 47.94 Billion KRW | 40.13% |
2019 FY | 44.72 Billion KRW | 30.71% |
2019 Q3 | 49.94 Billion KRW | 11.01% |
2019 Q4 | 44.72 Billion KRW | -10.47% |
2019 Q2 | 44.99 Billion KRW | -6.15% |
2018 Q4 | 34.21 Billion KRW | 2.89% |
2018 FY | 34.21 Billion KRW | 0.53% |
2018 Q1 | 36.27 Billion KRW | 6.6% |
2018 Q2 | 36.57 Billion KRW | 0.81% |
2018 Q3 | 33.25 Billion KRW | -9.08% |
2017 Q2 | 37.79 Billion KRW | -11.3% |
2017 FY | 34.03 Billion KRW | -21.66% |
2017 Q4 | 34.03 Billion KRW | -16.49% |
2017 Q3 | 40.75 Billion KRW | 7.83% |
2017 Q1 | 42.6 Billion KRW | -1.92% |
2016 Q1 | 47.12 Billion KRW | -21.92% |
2016 FY | 43.44 Billion KRW | -28.02% |
2016 Q3 | 38.76 Billion KRW | -19.5% |
2016 Q4 | 43.44 Billion KRW | 12.06% |
2016 Q2 | 48.15 Billion KRW | 2.19% |
2015 Q4 | 60.35 Billion KRW | -9.73% |
2015 Q3 | 66.85 Billion KRW | 0.0% |
2015 FY | 60.35 Billion KRW | -11.62% |
2014 FY | 68.28 Billion KRW | 218.43% |
2014 Q4 | 68.28 Billion KRW | 0.0% |
2013 FY | 21.44 Billion KRW | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Samyang Tongsang Co., Ltd | 28.44 Billion KRW | -1571.404% |
Uni-Chem Co., Ltd. | 73.96 Billion KRW | -542.807% |
Jayjun Cosmetic Co., Ltd. | 8.36 Billion KRW | -5581.206% |
BAIKSAN Co,. Ltd | 143.46 Billion KRW | -231.398% |
Hwaseung Enterprise Co., Ltd. | 951.18 Billion KRW | 50.018% |